For oxamyl, the Authority submitted a reasoned opinion on the existing MRLs in accordance with Article 12(2) of Regulation (EC) No 396/2005 in conjunction with Article 12(1) thereof ( 1 ). It recommended keeping the existing MRLs for certain products.